Selected References:
- Berge LN, et al. 1996. Pregnancy related changes in some cardiovascular risk factors. Acta Obstet. Gynecol. Scand. 75 pp. 439–442.
- France M, et al. 2016. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom. Atherosclerosis. 255:128-139.
- Goldberg AC et al. 2011. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel onFamilial Hypercholesterolemia. J Clin Lipidol. 2011 Jun;5(3 Suppl):S1-8.
- Jiang S et al. 2017. Maternal dyslipidemia during pregnancy may increase the risk of preterm birth: A meta-analysis. Taiwan J Obstet Gynecol. 56(1):9-15.
- Moayeri M, et al. 2017. Maternal lipid profile and the relation with spontaneous preterm delivery: a systematic review. Arch Gynecol Obstet. 295(2):313-323.
- Ogura et al. Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion. Atherosclerosis. 254:179-183.
- Pugh et al. 2017. Preconception maternal lipoprotein levels in relation to fecundability. Hum Reprod.15:1-9.
- Schisterman EF,et al. 2014. Lipid concentrations and couple fecundity: the LIFE study. J Clin Endocrinol Metab.99(8):2786-94.
- Schisterman EF, et al. 2014. Lipid concentrations and semen quality: the LIFE study. Andrology. 2(3):408-15.
- Toleikyte I, et al. 2011. Pregnancy outcomes in familial hypercholesterolemia: a registry-based study. Circulation. 124(15):1606-14.
- Varnier NA, et al. 2015. Coronary artery disease secondary to familial hypercholesterolaemia: An infrequent cause of increasingly common pregnancy co-morbidity. Obstet Med.8(3):152-4.
- Wang C, et al. 2016. The associations between early pregnancy lipid profiles and pregnancy outcomes. J Perinatol.
- Whitfield M, et al. 2015. Posttesticular sperm maturation, infertility, and hypercholesterolemia. Asian J Androl. 17(5):742-8.
